R C Bargou Selected Research

Immunotherapy

1/2017

Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R C Bargou Research Topics

Disease

6	Multiple Myeloma 07/2011 - 09/2001
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 09/2014
2	Neoplasms (Cancer) 01/2017 - 03/2000
2	Lymphoma (Lymphomas) 05/2003 - 03/2000
1	Bites and Stings (Sting) 01/2017
1	Residual Neoplasm 09/2014
1	Hodgkin Disease (Hodgkin's Disease) 04/2007
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2000

Drug/Important Bio-Agent (IBA)

3	blinatumomabIBA 01/2018 - 09/2014
3	Surface Antigens (Surface Antigen)IBA 01/2017 - 05/2003
2	Bispecific AntibodiesIBA 01/2017 - 03/2000
2	CytokinesIBA 07/2011 - 11/2004
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 09/2014
1	serum-glucocorticoid regulated kinaseIBA 07/2011
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 08/2008
1	Proteins (Proteins, Gene)FDA Link 04/2007
1	nutlin 3IBA 04/2007
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2007
1	Interleukin-6 (Interleukin 6)IBA 11/2004
1	CaspasesIBA 05/2003
1	SANT-7IBA 09/2001
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 09/2001
1	AntigensIBA 03/2000
1	AntibodiesIBA 03/2000
1	CD3 ComplexIBA 03/2000
1	Aligeron (AS 2)IBA 03/2000

Therapy/Procedure

1	Retreatment 01/2018
1	Immunotherapy 01/2017
1	Therapeutics 01/2017
1	Cell Transplantation 01/2017